diabetic kidney disease
Showing 1 - 25 of >10,000
Diabetic Kidney Disease Trial (Soleus ms exercise)
Not yet recruiting
- Diabetic Kidney Disease
- Soleus ms exercise
- (no location specified)
Nov 4, 2023
Revealing Engagement Dynamics Among Diabetic Kidney Disease
Not yet recruiting
- Diabetic Kidney Disease
-
San Francisco, CaliforniaPower Life Sciences
Oct 20, 2023
Prevent Diabetic Kidney Disease Among Egyptians
Not yet recruiting
- Diabetes Mellitus Without Complication
- (no location specified)
Oct 6, 2023
Thickening of Bowman's Capsule on Clinical Prognosis of Diabetic
Not yet recruiting
- Diabetic Kidney Disease
- Extracellular Matrix Alteration
- no intervention
- (no location specified)
Sep 15, 2023
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
Not yet recruiting
- Diabetic Kidney Disease
- cathepsin S and chromogranin A
- (no location specified)
Oct 5, 2023
Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)
Not yet recruiting
- Diabetic Kidney Disease
- Type 1 Diabetes
- Semaglutide
- Placebo
- (no location specified)
Apr 18, 2023
Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)
Recruiting
- Proteinuria
- +3 more
-
Hanzhou, Zhejiang, Chinathe Second Afficiated Hospital, Zhejiang University, School of M
Feb 22, 2023
Diabetic Kidney Disease, Diabetes Type 2, Chronic Kidney Diseases Trial
Not yet recruiting
- Diabetic Kidney Disease
- +3 more
- (no location specified)
Nov 23, 2022
Diabetic Kidney Disease Trial in Beijing (SPH3127+SPH3127matching +valsartan matching , SPH3127+valsartan matching , SPH3127
Not yet recruiting
- Diabetic Kidney Disease
- SPH3127+SPH3127matching placebo+valsartan matching placebo
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 9, 2023
Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Nov 8, 2023
Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,
Recruiting
- Diabetic Kidney Disease
- ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
-
Herlev, DenmarkDepartment of Nephrology, Herlev and Gentofte Hospital
May 31, 2023
Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)
Not yet recruiting
- Type2diabetes
- Diabetic Kidney Disease
- Investigational Product - MIB 626
- Placebo
- (no location specified)
Mar 6, 2023
Diabetic Nephropathies Trial in Mansoura (Valsartan 80 mg, Empagliflozin 10 MG, Levocetirizine)
Recruiting
- Diabetic Nephropathies
- Valsartan 80 mg
- +2 more
-
Mansoura, EgyptMansoura University
Nov 28, 2022
Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)
Recruiting
- Type2Diabetes
- ASCVD
- SGLT2 inhibitor
- +2 more
-
New York, New York
- +1 more
Dec 19, 2022
A Long-Term Follow-Up Study of Participants Exposed to REACT
Not yet recruiting
- Diabetic Kidney Disease
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jun 15, 2023
Diabetic Kidney Disease, CAKUT, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT))
Not yet recruiting
- Diabetic Kidney Disease
- +2 more
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jan 11, 2023
Diabetic Kidney Disease Trial in Sendai (Bardoxolone methyl, Placebo)
Active, not recruiting
- Diabetic Kidney Disease
- Bardoxolone methyl
- Placebo
-
Sendai, Miyagi, JapanJapan Community Health care Organization Sendai Hospital
Jun 26, 2022
Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)
Not yet recruiting
- Diabetic Kidney Disease
- IgA Nephropathy
- Placebo of SC0062
- +3 more
- (no location specified)
Jan 9, 2023
Diabetic Kidney Disease Trial in Taichung City (Probiotic group, Placebo group)
Not yet recruiting
- Diabetic Kidney Disease
- Probiotic group
- Placebo group
-
Taichung City, TaiwanChung Shan Medical University Hospital
Dec 29, 2022
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023
Diabetic Nephropathies, Diabetes, Type 2, Chronic Kidney Diseases Trial in Milwaukee (Individualized basic need navigation and
Recruiting
- Diabetic Nephropathies
- +3 more
- Individualized basic need navigation and lifestyle coaching and skills training
- Enhanced usual care
-
Milwaukee, WisconsinMedical College of Wisconsin
Aug 24, 2022
T2DM (Type 2 Diabetes), Metformin, SGLT2-Inhibitors Trial in Matsumoto (Tofogliflozin, Metformin)
Recruiting
- T2DM (Type 2 Diabetes Mellitus)
- +2 more
-
Matsumoto, Nagano, JapanShinshu University
Jul 21, 2022
Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)
Recruiting
- Diabetes Mellitus
- Diabetic Kidney Disease
- Dulaglutide
- +2 more
-
Sha Tin, Hong KongPrince of Wales Hospital
Nov 8, 2022